A patient suffering from migraine, whose symptoms were abolished by warfarin therapy, is reported. Warfarin was prescribed for deep vein thrombosis and the frequency of the patient's headache improved remarkably during the anticoagulant therapy. Because of the unusual nature of the response to anticoagulant therapy, warfarin was reintroduced on a double blind (versus placebo) basis and once again abolished the headaches.
Introduction
Sporadic case reports",2 in the literature have suggested the disappearance of migrainous headaches with anticoagulant therapy. The mechanism of action of warfarin in vascular headache is unclear, however, studies have shown increased platelet aggregation and hypercoagulable plasma in patients with migraine.'-' We report the case of a 71 year old woman whose migrainous headaches were abolished with warfarin therapy for deep vein thrombosis.
Case report
A 71 year old lady, with a long-standing history of migraine and angina, was admitted to the acute medical ward with swelling of the left leg and thigh. The swelling appeared 3 days prior to the admission and was progressively increasing in size. She was a long-term sufferer of migraine and many therapies had previously been tried. The headache most often was left sided and was frequently associated with vomiting and photophobia. Occasionally, vomiting relieved the headache. Paracetamol often was helpful during periods of headache; however, she occasionally had to resort to ergotamine tartrate tablet for relief of the headache. She continued to have migrane, 3-4 per week, despite prophylactic treatment with methysergide, which has been found to be the most effective of her many therapies.
A venogram confirmed the presence of thrombosis in the deep veins of the calf, femoral and iliac veins on the left side. A computerized tomographic She was commenced on warfarin sodium and The platelets of migrainous patients have a greater tendency to aggregate4'5 and during the headache phase show increased adhesiveness. Some patients with migraine have been shown to have hypercoagulable plasma.6 There have been isolated reports to suggest a decreased anticoagulant sensitivity after migrainous attacks,7 however it is not clear whether this phenomenon is due to increase in the blood levels of vitamin K-dependent clotting factors. The mechanism behind the reduction of migrainous headaches during warfarin treatment on our patient is unclear, however, the dramatic response leads one to suggest that in the very resistant patient, anticoagulants may be an alternative therapy. 
